NASDAQ:BKYI - BIO-key International Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $6.00
  • Forecasted Upside: 81.82 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$3.30
▲ +0.1 (3.13%)

This chart shows the closing price for BKYI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New BIO-key International Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BKYI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BKYI

Analyst Price Target is $6.00
▲ +81.82% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for BIO-key International in the last 3 months. The average price target is $6.00, with a high forecast of $6.00 and a low forecast of $6.00. The average price target represents a 81.82% upside from the last price of $3.30.

This chart shows the closing price for BKYI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 1 polled investment analysts is to buy stock in BIO-key International. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/10/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/10/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/8/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/6/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/4/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/5/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/4/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/3/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/26/2021Maxim GroupUpgradeHold ➝ Buy$6.00High
8/11/2020Maxim GroupReiterated RatingHoldHigh
10/4/2019Maxim GroupDowngradeBuy ➝ HoldLow
8/30/2019Maxim GroupSet Price TargetBuy$2.00Low
7/29/2019Maxim GroupReiterated RatingBuy$2.25Low
4/2/2019Maxim GroupReiterated RatingBuy$4.00Low
11/15/2018Maxim GroupReiterated RatingBuy$4.00Medium
8/16/2018Maxim GroupLower Price TargetBuy ➝ Buy$5.50 ➝ $5.00Low
4/24/2018Maxim GroupInitiated CoverageBuy ➝ Buy$5.50Medium
3/29/2018Maxim GroupSet Price TargetBuy$6.00High
12/21/2017Maxim GroupReiterated RatingBuy$5.50Low
7/13/2017Maxim GroupInitiated CoverageBuy ➝ Buy$5.50N/A
(Data available from 8/3/2016 forward)
BIO-key International logo
BIO-key International, Inc. engages in the provision of identity and access management (IAM) platform. The firm's products include multi-factor authentication, self-service password reset, single sign-on, fingerprint scanners, and civil and large-scale identification. It offers its services to the education, financial, government, healthcare, manufacturing, and retail industries. The company was founded on January 7, 1993 and is headquartered in Wall, NJ.
Read More

Today's Range

Now: $3.30
Low: $3.17
High: $3.30

50 Day Range

MA: $3.71
Low: $3.13
High: $4.11

52 Week Range

Now: $3.30
Low: $2.75
High: $7.20

Volume

45,864 shs

Average Volume

311,310 shs

Market Capitalization

$25.81 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.01

Frequently Asked Questions

What sell-side analysts currently cover shares of BIO-key International?

The following Wall Street sell-side analysts have issued reports on BIO-key International in the last twelve months: Maxim Group.
View the latest analyst ratings for BKYI.

What is the current price target for BIO-key International?

1 Wall Street analysts have set twelve-month price targets for BIO-key International in the last year. Their average twelve-month price target is $6.00, suggesting a possible upside of 81.8%. Maxim Group has the highest price target set, predicting BKYI will reach $6.00 in the next twelve months. Maxim Group has the lowest price target set, forecasting a price of $6.00 for BIO-key International in the next year.
View the latest price targets for BKYI.

What is the current consensus analyst rating for BIO-key International?

BIO-key International currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe BKYI will outperform the market and that investors should add to their positions of BIO-key International.
View the latest ratings for BKYI.

What other companies compete with BIO-key International?

Other companies that are similar to BIO-key International include Intrusion, B.O.S. Better Online Solutions, Ezenia!, Avistar Communications, China Crescent Enterprises and Invent Ventures.

How do I contact BIO-key International's investor relations team?

BIO-key International's physical mailing address is 3349 HIGHWAY 138 BUILDING A SUITE E, WALL NJ, 07719. The technology company's listed phone number is (732) 359-1100 and its investor relations email address is [email protected] The official website for BIO-key International is www.bio-key.com.